SCHEMBL74271

SCHEMBL74271

C=CC(=O)Oc1ccc(C2CCC(C3CCC(CCC)CC3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.53
MAPT P10636 2/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
THRB P10828 3/20 0.48
MEN1 O00255 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
ESR2 Q92731 4/20 0.38
RAB9A P51151 1/20 0.37
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
TLR4 O00206 1/20 0.34
DRD2 P14416 1/20 0.34
THRA P10827 1/20 0.34
LSS P48449 2/20 0.33
DGAT1 O75907 1/20 0.33
SOAT1 P35610 1/20 0.33
ESR1 P03372 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1655552 0.96 CYP2C9 (0.57) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL74879 0.96 CYP2C9 (0.57) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL76060 0.93 THRB (0.49) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL12386500 0.93 CYP2C9 (0.53) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL14373526 0.89 CYP2C9 (0.50) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL8834978 0.89 THRB (0.52) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL75087 0.89 THRB (0.52) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL11917933 0.88 CYP2C9 (0.49) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL816087 0.88 THRB (0.54) CYP2C9MAPTALDH1A1LMNATHRB
SCHEMBL13614299 0.86 CYP2C9 (0.41) CYP2C9MAPTALDH1A1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200301213-A1 LIQUID CRYSTAL DISPLAY ELEMENT AND METHOD FOR MANUFACTURING SAME DIC CORPORATION (JP) 2020-09-24 US disclosed
US-10344214-B2 Liquid crystal display device and method for manufacturing the same DIC CORPORATION (JP) 2019-07-09 US disclosed
US-20180142155-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME DIC CORPORATION (JP) 2018-05-24 US disclosed
US-20180142155-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME DIC CORPORATION (JP) 2018-05-24 US disclosed
EP-2955570-B1 LIQUID CRYSTAL DISPLAY ELEMENT AND MANUFACTURING METHOD FOR SAME DAINIPPON INK & CHEMICALS (JP) 2018-03-28 EP disclosed
US-20170321122-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME DIC CORPORATION (JP) 2017-11-09 US disclosed
US-20170321122-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME DIC CORPORATION (JP) 2017-11-09 US disclosed
US-9719017-B2 Liquid crystal display device and method for manufacturing the same DIC CORPORATION (JP) 2017-08-01 US disclosed
US-9719017-B2 Liquid crystal display device and method for manufacturing the same DIC CORPORATION (JP) 2017-08-01 US disclosed
US-20160108316-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME DIC CORPORATION (JP) 2016-04-21 US disclosed
US-20080291377-A1 Liquid Crystal Display Device and Manufacturing Method Thereof HITACHI DISPLAYS, LTD. (JP) 2008-11-27 US disclosed
US-20080081133-A1 Trifunctional compound, composition and polymer thereof CHISSO CORPORATION 2008-04-03 US disclosed
US-20080081133-A1 Trifunctional compound, composition and polymer thereof CHISSO CORPORATION 2008-04-03 US disclosed
US-20080074588-A1 LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF MAGNOLIA PURPLE CORPORATION (JP) 2008-03-27 US disclosed
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof CHISSO CORPORATION 2007-06-14 US disclosed
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof CHISSO CORPORATION 2007-06-14 US disclosed
US-20070134440-A1 Lateral oxirane compound and polymer thereof CHISSO CORPORATION 2007-06-14 US disclosed
US-20070134440-A1 Lateral oxirane compound and polymer thereof CHISSO CORPORATION 2007-06-14 US disclosed
US-20070026165-A1 Liquid crystal display and manufacturing method of same DAI NIPPON PRINTING CO., LTD. (JP) 2007-02-01 US disclosed
US-20070026165-A1 Liquid crystal display and manufacturing method of same DAI NIPPON PRINTING CO., LTD. (JP) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081133-A1 Trifunctional compound, composition and polymer thereof OXER1, AFF1, OXGR1 CYP2C9 827/4885MAPT 3039/4885ALDH1A1 349/4885
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof AFF1, CNKSR1, LEF1 CYP2C9 4328/4885MAPT 3961/4885ALDH1A1 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.